glp 1 obesidad La FDA aprueba el primer GLP-1 genérico para la pérdida de peso – SOCHOB Avances en el tratamiento de

A common feature of the GLP-1 analogs is the dose-dependent appearance of gastrointestinal adverse effects, most commonly nausea, vomiting, and diarrhea

doi: 10.1677/joe.0.1160357

By influencing appetite and reducing caloric intake, Ozempic helps patients manage their weight

Diabetes Obes Metab 2010

GLP-1 has many levels of action, but currently it is primarily known for its effect on beta cells (the peptide lowers blood sugar by stimulating insulin secretion, which augments pancreas response within a safe glycemic range without inducing hypoglycemia)

however, most phase III clinical studies are of insufficient duration and do not include enough study participants to effectively gauge long-term safety